Home > Insider Trading > Filing (0001870913-23-000003)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Ani Pharmaceuticals Inc	ANIP	Pharmaceutical Preparations (2834)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1870913	Muthusamy Shanmugam	C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623	Head Of R&D, Coo-Novitium Ops	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-08-14	27,890	$61.15	1,204,730	No	4	S	Indirect	Held by Esjay LLC
Common Stock	Disposition	2023-08-15	22,110	$61.60	1,182,620	No	4	S	Indirect	Held by Esjay LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Esjay LLC
No	4	S	Indirect	Held by Esjay LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	47,407	Direct
Common Stock	5,000	Indirect	Held by SS Pharma LLC

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 21, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.12 to $62.58, inclusive.
The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $60.81 to $62.59, inclusive.
The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.